NIH-funded research R01 grant

Understanding how certain proteins affect T cell behavior during infections

Official title: Epigenetic regulation of T cell differentiation during infection

Funded at Univ of North Carolina Chapel Hill · NIH-11121015 · Data updated 2026-11-12

This study is looking at how certain proteins affect the way immune cells called CD8 T cells work during infections and cancer, with the hope of finding better treatments for patients dealing with these conditions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startJune 18, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$559,331
NIH project number5R01AI177864-02
Project IDNIH-11121015 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with chronic infections or cancers that affect T cell function.

Less likely to help

Patients with acute infections or those not affected by T cell exhaustion may not receive benefit from this research.

What this research studies

This research investigates the role of specific proteins known as BET family members in the differentiation and exhaustion of CD8 T cells during infections and cancer. By using advanced genetic techniques in mouse models, the study aims to uncover how these proteins influence T cell function and could potentially lead to improved therapies. The goal is to enhance our understanding of T cell biology and optimize treatments that target these proteins to combat chronic infections and cancers. Patients may benefit from insights that could lead to more effective immunotherapies.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for reprogramming exhausted T cells, improving immune responses in patients with chronic infections and cancers.

How similar studies have gone: Previous research has shown mixed results with BET inhibitors in clinical trials, indicating that while the approach is promising, it requires further investigation.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Milner, John Justin — Univ of North Carolina Chapel Hill
  • Study coordinator: Milner, John Justin

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.